Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05280184 · ClinicalTrials.gov registry record · NA

Coin2Dose: Behavioral Economics to Promote Insulin BOLUS Activity and Improve HbA1c in Teens

A NA study, sponsored by Nemours Children's Clinic.

Completed
Registry status
NA
Development phase
173
Enrollment target

NCT05280184: Completed NA study, sponsored by Nemours Children's Clinic.

NCT05280184 is a NA study that has completed, run by Nemours Children's Clinic. The registered enrollment target is 173 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05280184, a NA study, has completed, sponsored by Nemours Children's Clinic.

COMPLETED
Registry status
NA
Development phase
173 participants
Enrollment target

Study Summary

Our objective is to test the feasibility, acceptability, and initial efficacy of using behavioral economics incentives (BEI) in a novel, semi-automated intervention to target daily insulin BOLUS scores in adolescents with suboptimal insulin use.

Primary Outcome

proxy measure of average glycemic levels

Interventions

  • BEHAVIORAL Coin2Dose

Trial Details

FieldValue
Enrollment Target 173 participants
Start Date 2023-01-01
Est. Completion 2025-09-30
Phase NA
Nemours Children's Clinic

108 total trials

What the finished NCT05280184 record still lists

NCT05280184 is an interventional study that assigns participants to a tested intervention. The registered 173 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 1 intervention - of which Coin2Dose is the first listed.

NCT05280184 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05280184 about?

NCT05280184 is a clinical study titled "Coin2Dose: Behavioral Economics to Promote Insulin BOLUS Activity and Improve HbA1c in Teens". Our objective is to test the feasibility, acceptability, and initial efficacy of using behavioral economics incentives (BEI) in a novel, semi-automated intervention to target daily insulin BOLUS scores in adolescents with suboptimal insulin use.

What is the current status of trial NCT05280184?

This trial is currently completed. It is a NA study. The enrollment target is 173 participants. The study started on 2023-01-01. Estimated completion is 2025-09-30.

What interventions are being tested in trial NCT05280184?

The interventions under investigation include: Coin2Dose (BEHAVIORAL).

Who is sponsoring clinical trial NCT05280184?

This trial is sponsored by Nemours Children's Clinic, which has 108 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05280184's enrollment target sits among peer trials

173 611th of 2000 higher than 1,389 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05568719 · 173 participants · Phase 3

    Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

  • NCT07070115 · 173 participants · NA

    Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®

  • NCT07150832 · 173 participants · NA

    Efficacy of the I-CARE Digital Health Intervention

  • NCT01000259 · 174 participants

    Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05280184, the US trial registry maintained by the National Library of Medicine. NCT05280184 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.